Table 4.

Proportional Reporting Ratios and corresponding CIs for preferred terms from MedDRA

	PRR	95% CI	PRR	95% CI	PRR	95% CI	PRR	95% CI	PRR	95% CI	PRR	95% CI
Bronchitis	Apixaban		Dabigatran		Edoxaban		Heparin		Rivaroxaban		Warfarin
Cough	1.93	1.46	1.2	0.75	1.28	0.48	0.61	0.40	0.46	0.34	1.5	1.17
Dysphonia	2.06	1.76	0.7	0.50	2.07	1.32	0.43	0.33	0.62	0.53	1.35	1.17
Dyspnoea	2.01	1.42	0.19	0.05	0.52	0.07	0.34	0.17	0.51	0.36	2.07	1.53
Emphysema	1.4	1.27	0.95	0.81	1.52	1.14	1.02	0.92	0.7	0.64	1.12	1.04
Nasopharyngitis	2.09	1.05	NA	NA	NA	NA	0.8	0.31	0.48	0.23	1.73	0.95
Oropharyngeal pain	1.89	1.48	0.56	0.32	0.49	0.12	0.18	0.09	0.65	0.51	1.83	1.49
Pleural effusion	1.52	1.09	0.75	0.40	1.97	0.81	0.34	0.19	0.56	0.41	1.93	1.48
Pleurisy	1.06	0.83	1.4	1.02	0.51	0.16	1.72	1.40	0.58	0.47	1.05	0.87
Pneumonia	0.42	0.10	1.11	0.26	2.89	0.39	0.9	0.31	0.75	0.34	1.74	0.85
Pneumonia aspiration	1.4	1.23	1.03	0.83	1.57	1.07	1.31	1.14	0.65	0.58	1	0.90
Pulmonary edema	0.97	0.63	1.09	0.59	4.17	2.05	1.37	0.93	0.72	0.51	0.97	0.70
Sinusitis	1.2	0.86	0.59	0.30	0.68	0.17	2.58	1.97	0.46	0.34	1	0.77
	1.66	1.16	0.78	0.39	0.51	0.07	0.3	0.15	0.63	0.45	1.82	1.35